Trials & Litigation
Negative Vytorin Study Prompts Lawsuits
Posted Jan 28, 2008, 07:28 am CDT
By Debra Cassens Weiss
Reports that Vytorin is no more effective than generic drugs in battling cholesterol have already generated lawsuits.
The suits claim drug makers Merck & Co. Inc. and Schering-Plough Corp. delayed release of the negative study while touting the drug’s benefits, the National Law Journal reports.
Lawyer Steve Berman of Seattle filed a federal suit on Jan. 17 in New Jersey. The same day lawyer David Rheingold filed suit on behalf of his wife, a Vytorin user, in federal court in New York.
Berman’s suit seeks refunds for consumers who bought the drug. "They were paying out of pocket because they were told [Vytorin] would lower their plaque,” he told the newspaper. “They wouldn't have paid for it if the drug was truthfully marketed."
Related Stories
- Mervyn’s Sues Its Ex-Owners Over ‘Fraudulent Transfer’ of Stores
Sep 4, 2008, 08:24 pm CDT - Sunglasses Issue Obscures Case Outcome
Sep 4, 2008, 04:54 pm CDT - Arnstein Plans Major Growth in Florida
Sep 4, 2008, 04:31 pm CDT - Abramoff Gets 4 Years, After Prosecution Urges Leniency
Sep 4, 2008, 03:52 pm CDT
Related Topics
Commenting has expired on this post.
Comments
Be the first to comment.